Open | $16.510 |
Close | $15.830 |
Volume / Avg. | 209.954K / 168.785K |
Day Range | 15.600 - 16.790 |
52 Wk Range | 9.162 - 21.704 |
Market Cap | $406.936M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 1.96% |
Days to Cover | 3.53 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AVITA Medical (NASDAQ: RCEL) through any online brokerage.
Other companies in AVITA Medical’s space includes: Renovaro (NASDAQ:RENB), Humacyte (NASDAQ:HUMA), Celcuity (NASDAQ:CELC), Inozyme Pharma (NASDAQ:INZY) and Korro Bio (NASDAQ:KRRO).
The latest price target for AVITA Medical (NASDAQ: RCEL) was reported by Piper Sandler on Friday, February 23, 2024. The analyst firm set a price target for 21.00 expecting RCEL to rise to within 12 months (a possible 32.66% upside). 17 analyst firms have reported ratings in the last year.
The stock price for AVITA Medical (NASDAQ: RCEL) is $15.83 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for AVITA Medical.
AVITA Medical’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for AVITA Medical.
AVITA Medical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.